These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 36278951)

  • 61. A review of recent advances in the diagnosis of cardiac amyloidosis, treatment of its cardiac complications, and disease-modifying therapies.
    Raval M; Siddiq S; Sharma K; Sanghvi L; Jain A; Patel S; Trivedi J; Uttam Chandani K; Patel D; Desai R
    F1000Res; 2023; 12():192. PubMed ID: 36911240
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cardiac amyloidosis - experience in a tertiary cardiac referral centre.
    Chau EM; Chow WH; Wang E; Kwong YL
    Int J Cardiol; 2008 Feb; 124(2):264-6. PubMed ID: 17383027
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Outcomes in Patients With Cardiac Amyloidosis Undergoing Heart Transplantation.
    Barrett CD; Alexander KM; Zhao H; Haddad F; Cheng P; Liao R; Wheeler MT; Liedtke M; Schrier S; Arai S; Weisshaar D; Witteles RM
    JACC Heart Fail; 2020 Jun; 8(6):461-468. PubMed ID: 32387068
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Updates for the diagnosis and management of cardiac amyloidosis.
    Gościniak P; Baron T; Milczarek S; Kostkiewicz M; Machaliński B
    Adv Clin Exp Med; 2022 Feb; 31(2):175-185. PubMed ID: 35195962
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A novel variant of transthyretin, 59Thr-->Lys, associated with autosomal dominant cardiac amyloidosis in an Italian family.
    Booth DR; Tan SY; Hawkins PN; Pepys MB; Frustaci A
    Circulation; 1995 Feb; 91(4):962-7. PubMed ID: 7850982
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Editorial commentary: Heart rate and rhythm in cardiac amyloidosis.
    Sperry BW; Sandesara UB; Kline JA
    Trends Cardiovasc Med; 2024 May; 34(4):254-256. PubMed ID: 36977449
    [No Abstract]   [Full Text] [Related]  

  • 67. Diagnosis of cardiac amyloidosis by magnetic resonance imaging due to a new mutation in the transthyretin gene.
    Damy T; Plante-Bordeneuve V; Valleix S
    Arch Cardiovasc Dis; 2012 Nov; 105(11):614-5. PubMed ID: 23177490
    [No Abstract]   [Full Text] [Related]  

  • 68. Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis.
    Solomon SD; Adams D; Kristen A; Grogan M; González-Duarte A; Maurer MS; Merlini G; Damy T; Slama MS; Brannagan TH; Dispenzieri A; Berk JL; Shah AM; Garg P; Vaishnaw A; Karsten V; Chen J; Gollob J; Vest J; Suhr O
    Circulation; 2019 Jan; 139(4):431-443. PubMed ID: 30586695
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Diagnosis and Treatment of Transthyretin Cardiac Amyloidosis. Progress and Hope.
    González-López E; López-Sainz Á; Garcia-Pavia P
    Rev Esp Cardiol (Engl Ed); 2017 Nov; 70(11):991-1004. PubMed ID: 28870641
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Primer on the Differential Diagnosis and Workup for Transthyretin Cardiac Amyloidosis.
    Sperry BW; Vadalia A
    Am J Cardiol; 2022 Dec; 185 Suppl 1():S11-S16. PubMed ID: 36549787
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Recent Progress in the Development and Clinical Application of New Drugs for Transthyretin Cardiac Amyloidosis.
    Zhou J; Li Y; Geng J; Zhou H; Liu L; Peng X
    J Cardiovasc Pharmacol; 2023 Dec; 82(6):427-437. PubMed ID: 37678276
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice.
    Witteles RM; Bokhari S; Damy T; Elliott PM; Falk RH; Fine NM; Gospodinova M; Obici L; Rapezzi C; Garcia-Pavia P
    JACC Heart Fail; 2019 Aug; 7(8):709-716. PubMed ID: 31302046
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report.
    Yamamoto H; Hashimoto T; Kawamura S; Hiroe M; Yamashita T; Ando Y; Yokochi T
    J Med Case Rep; 2018 Dec; 12(1):370. PubMed ID: 30553273
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Heart transplantation in cardiac amyloidosis.
    Sousa M; Monohan G; Rajagopalan N; Grigorian A; Guglin M
    Heart Fail Rev; 2017 May; 22(3):317-327. PubMed ID: 28281017
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Suspected cardiac amyloidosis - diagnostic steps for evaluation].
    Feldmann K; Hamm CW; Aßmus B
    Dtsch Med Wochenschr; 2020 Aug; 145(16):1162-1168. PubMed ID: 32791553
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Diagnosis and management of the cardiac amyloidoses.
    Falk RH
    Circulation; 2005 Sep; 112(13):2047-60. PubMed ID: 16186440
    [No Abstract]   [Full Text] [Related]  

  • 77. Pressure-volume relationships in patients with transthyretin (ATTR) cardiac amyloidosis secondary to V122I mutations and wild-type transthyretin: Transthyretin Cardiac Amyloid Study (TRACS).
    Bhuiyan T; Helmke S; Patel AR; Ruberg FL; Packman J; Cheung K; Grogan D; Maurer MS
    Circ Heart Fail; 2011 Mar; 4(2):121-8. PubMed ID: 21191093
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Cardiac amyloidosis: review of the literature].
    Gouveia D; Carranca J; Lousada N; Adão M; Ferreira T; Pereira T; Correia M
    Rev Port Cardiol; 1996 Sep; 15(9):657-64, 613. PubMed ID: 9081319
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Transthyretin amyloidoses].
    Magy-Bertrand N
    Rev Med Interne; 2007 May; 28(5):306-13. PubMed ID: 17316923
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cardiac manifestations of amyloid disease.
    Rivera RJ; Vicenty S
    Bol Asoc Med P R; 2008; 100(4):60-70. PubMed ID: 19400531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.